Linc00205/Mir-495-3p/Tnfsf15 Axis is Implicated in the Treatment Effect of Hyperbaric Oxygen Therapy on Patients with Post-Stroke Cognitive Impairment | Canada Hyperbarics Skip to main content
Study Noro Psikiyatr Ars 2025

Linc00205/Mir-495-3p/Tnfsf15 Axis is Implicated in the Treatment Effect of Hyperbaric Oxygen Therapy on Patients with Post-Stroke Cognitive Impairment

Yang X, Chen M, Shen Z, Rong T, Feng J, Wu M, et al. — Noro Psikiyatr Ars, 2025

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers investigated how hyperbaric oxygen therapy affects cognitive problems after a stroke, also looking at changes in specific genes and inflammatory markers in the blood.

What They Found

Patients receiving hyperbaric oxygen (HBO) therapy showed higher cognitive scores at 6 months compared to those receiving conventional treatment. The HBO group also had higher levels of anti-inflammatory factors (IL-4, IL-10) and lower levels of pro-inflammatory factors (IL-2, IL-6, TNF-α, IFN-α, IL-17A) in their blood. The study identified a specific gene network, LINC00205-hsa-miR-495-3p-TNFSF15, that may be involved in how HBO therapy works.

Canadian Relevance

No direct Canadian connection identified. Post-stroke cognitive impairment is not a Health Canada-recognised indication for hyperbaric oxygen therapy.

Study Limitations

The abstract does not specify the exact hyperbaric oxygen therapy protocol used, such as the pressure (ATA) or number of sessions.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Study
Category Neurological
Source Pubmed
PubMed ID 40046208
Year Published 2025
Journal Noro Psikiyatr Ars

Cite This Study

Share
Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 16, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology